S&P 5007,600.50▲1.5% Nasdaq25,913.90▲2.1% Dow53,178.41▲1.3% Russell 2K2,981.91▲1.7% 10-Yr4.69%−6bp VIX15.86−0.13 WTI$80.00▼5.5% Gold$4,106.70▲1.4% EUR/USD1.151▼0.1% BTC$64,182▲1.1% Nikkei64,362▲4.0%
At close · Mon, Aug 3, 2026
Daily Market Updates.

Earnings

Home›Earnings›Previews›Novo Nordisk shares fall after Wegovy miss and outlook…

Novo Nordisk shares fall after Wegovy miss and outlook update

The company reported a surprise miss tied to Wegovy, but also said it has improved its outlook for the year.

Reported · Written up by our desk · Previews

Novo Nordisk shares slid again after the drugmaker disclosed a surprise miss tied to Wegovy, the weight loss treatment linked to its broader results, MarketWatch reported.

Alongside the miss, Novo Nordisk also provided an improved outlook for the year, according to the outlet, offering some offset to the weaker-than-expected performance tied to the product.

← Newer storyStormlands model lifts Fremont gold NPV by 101%

More like this

EarningsPalantir targets continued revenue acceleration as U.S. growth remains key
EarningsKey stocks set for earnings week as option volatility spikes
EarningsHasbro details lessons from cyberattack in Yahoo Finance feature
EarningsSpaceX stock faces first earnings report after IPO selloff
EarningsSpaceX, AMD and other tech names set for earnings after the bell

Sources

MarketWatchNovo Nordisk stock is sliding again , and the Wegovy pill’s surprise miss is partly to blame
MarketWatchNovo Nordisk stock is sliding again , and the Wegovy pill’s surprise miss is partly to blame

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.